Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Ratan Tata Joins Nanobiosym Global Advisory Board

Mr. Ratan Tata joins Nanobiosym Global Advisory Board (PHOTO: Business Wire)
Mr. Ratan Tata joins Nanobiosym Global Advisory Board (PHOTO: Business Wire)

Tata to advise leading nanotech firm as it brings pioneering innovations to global markets

Ratan Tata Joins Nanobiosym Global Advisory Board

Boston, MA | Posted on September 15th, 2008

Nanobiosym®, a leading nanotechnology firm, today announced that Mr. Ratan Tata, chairman of the multibillion-dollar global conglomerate Tata Group, has joined the firm's global advisory board.

"I am honored to welcome Mr. Tata to our Global Advisory Board," said Nanobiosym® Chairman and CEO, Dr. Anita Goel, MD, PhD- a Harvard and MIT-trained physicist and physician. "I am inspired by his example, which provides us with a practical roadmap for bringing cutting edge technologies into emerging global economies and extending our reach to broad markets at the ‘bottom of the pyramid'."

Nanobiosym® has developed Gene-RADAR®, a portable nanotechnology platform that can rapidly and accurately detect genetic fingerprints from any biological organism. Dr. Goel's vision is to give patients worldwide real-time access to their own diagnostic information through low-cost handheld devices that could detect disease from a single drop of blood or saliva.

"Nanotechnology has the potential to revolutionize the way we tackle key issues facing the world today, and Nanobiosym® is working at the forefront of this revolution," Mr. Tata said. "Dr. Goel has forged a bold model for driving technological innovation and commercialization, while maximizing global humanitarian impact. I am delighted to join the Nanobiosym® Global Advisory Board, and I look forward to working closely with Dr. Goel and her team."

Mr. Alfred Ford, Director of the Ford Motor Company Fund and also a member of the Nanobiosym® Global Advisory Board, said: "Behind this vision is game-changing technology which can revolutionize healthcare globally. In the face of growing world health crises and transnational epidemics, Dr. Goel and Nanobiosym® are redefining the rules in the battle to diagnose disease and save lives."

Imagine the possibilities when a pioneer like Dr. Goel, named one of MIT Technology Review's top 35 science and technology innovators in the world, aligns with a global entrepreneur like Mr. Tata, named one of Time Magazine's 100 most influential people in the world. Very big - and very, very small - things can happen.

"Dr. Goel sees far over the horizon, beyond geographic and technological boundaries, and envisions technology driven by the needs of the greater good -- a vision that we both share," Mr. Tata said.

The Nanobiosym Chairman and CEO added, "We are deeply committed to bringing our nanotech innovations into global markets to address some of the greatest unmet humanitarian needs of our time."


About Nanobiosym®
Nanobiosym® and its commercial engine Nanobiosym® Diagnostics create and commercialize breakthrough technologies at the nexus of physics, biomedicine, and nanotechnology. Its Gene-RADAR® technology platform will empower people worldwide with rapid, accurate and portable diagnostic information about their own health. Nanobiosym’s® Global Advisory Board comprises global thought leaders who provide guidance and strategic vision to help Nanobiosym® realize its mission. Nanobiosym® and its Board work closely with governmental, NGO, and commercial partners to bring its revolutionary technology platforms into developed and emerging world markets.

About Dr. Anita Goel

Dr. Anita Goel, M.D., Ph.D., Chairman and CEO of Nanobiosym®, is an internationally recognized nanotech expert and entrepreneur. Dr. Goel’s pioneering contributions to the interface of physics, medicine, and nanotechnology over the past 15 years have been recognized globally by several prestigious honors and funding awards from the United States Department of Defense agencies including Defense Advanced Research Projects Agency (DARPA), Air Force Office of Scientific Research (AFOSR), U.S. Department of Energy (DOE) and the U.S. Defense Threat Reduction Agency (DTRA). In 2005 Dr. Goel was named one of the world’s “Top 35 Science and Technology Innovators under the age of 35” by MIT’s Technology Review magazine and in 2006 received MIT’s Global Indus Technovator Award, an honor that recognizes the contributions of the top 10 leaders working globally at the forefront of science, technology, and entrepreneurship. Dr. Goel holds both a Ph.D. in physics from Harvard University and an M.D. from the Harvard-MIT Joint Division of Health Sciences and Technology (HST).

About Mr. Ratan N. Tata

Mr. Ratan N. Tata is Chairman of Tata Sons, the holding company for the Tata Group, the multibillion dollar Indian conglomerate. He is also the Chairman of two of the largest philanthropic trusts in India. Mr. Tata is a member of the Asia-Pacific Advisory Committee to the Board of Directors of the New York Stock Exchange and the International Advisory Council of Singapore's Economic Development Board, and of the advisory boards of the Mitsubishi Corporation, JP Morgan Chase and Rolls Royce. Mr. Tata serves as President of the Court of the Indian Institute of Science and Chairman of the Tata Institute of Fundamental Research. He is a member of the Board of Trustees of Cornell University and the University of Southern California, as well as the Global Business Council on HIV/AIDS and the Program Board of the Gates Foundation's India AIDS Initiative. He was recently named one of Time Magazine's '100 Most Influential People of 2008,'

For more information, please click here

For Nanobiosym
Media Relations:
Jen Wilson

Copyright © Business Wire 2008

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Tiny bubbles provide tremendous propulsion in new microparticles research-Ben-Gurion U. June 21st, 2017

Enhanced photocatalytic activity by Cu2O nanoparticles integrated H2Ti3O7 nanotubes June 21st, 2017

Researchers developed nanoparticle based contrast agent for dual modal imaging of cancer June 21st, 2017

Oxford Instruments congratulates Lancaster University for inaugurating the IsoLab, built for studying quantum systems June 20th, 2017


Tiny bubbles provide tremendous propulsion in new microparticles research-Ben-Gurion U. June 21st, 2017

Enhanced photocatalytic activity by Cu2O nanoparticles integrated H2Ti3O7 nanotubes June 21st, 2017

Researchers developed nanoparticle based contrast agent for dual modal imaging of cancer June 21st, 2017

Cambridge Nanotherm partners with Inabata for global sales and distribution June 20th, 2017

Appointments/Promotions/New hires/Resignations/Deaths

Nanometrics Announces Retirement Plans of CEO Timothy Stultz: Dr. Stultz to Continue as Director May 25th, 2017

180 Degree Capital Corp. Announces the Start of Kevin Rendino as Chairman and Chief Executive Officer and Completion of its Transition to a Registered Closed-End Fund March 31st, 2017

Francis Alexander Named Deputy Director of Brookhaven Lab's Computational Science Initiative February 16th, 2017

Nanobiotix appoints senior executive from pharmaceutical industry, as Chief Operating Officer: Oncology industry veteran to oversee operations and product commercialization February 8th, 2017

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project